➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Dow
Harvard Business School
Mallinckrodt
Moodys

Last Updated: January 26, 2021

DrugPatentWatch Database Preview

Litigation Details for SUCAMPO AG v. SUN PHARMACEUTICAL INDUSTRIES, LTD. (D.N.J. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

SUCAMPO AG v. SUN PHARMACEUTICAL INDUSTRIES, LTD. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-10-30
Court District Court, D. New Jersey Date Terminated 2020-07-01
Cause 15:1126 Patent Infringement Assigned To Freda L. Wolfson
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties SUCAMPO PHARMACEUTICALS, INC.
Patents 7,795,312; 8,026,393; 8,097,653; 8,338,639; 8,389,542; 8,748,481; 8,779,187
Attorneys WILLIAM C. BATON
Firms Rivkin Radler, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in SUCAMPO AG v. SUN PHARMACEUTICAL INDUSTRIES, LTD.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for SUCAMPO AG v. SUN PHARMACEUTICAL INDUSTRIES, LTD. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-10-30 1 Sucampo AG owns United States Patent No. 7,795,312 (“the ’312 patent”) titled, “Method for Treating…action for infringement of United States Patent Nos. 7,795,312, 8,097,653, 8,389,542, 8,026,393, 8,338,639…of the ’312 patent, Claims 1-13 of the ’542 patent, Claims 1-9 and 11-21 of the ’393 patent, Claims 1-…481 patents, or any later expiration of any patent term extension or exclusivity for these patents to …of 103 PageID: 5 “the patents-in-suit”). This action arises under the Patent Laws of the United States External link to document
2020-07-01 34 Order of Dismissal United States Patent Nos. 7,795,312 (“the ’312 Patent”) , 8,026,393 (“the ’393 Patent”), 8,097,653 (… (“the ’653 Patent”), 8,338,639 (“the ’639 Patent”), 8,389,542 (“the ’542 Patent”), 8,748,481 (“the ’… ’481 Patent”), and 8,779,187 (“the ’187 Patent”) (collectively, the “Sucampo Patents”). Plaintiffs’ …INJUNCTION This action for patent infringement (the “Patent Litigation”) has been brought by …charges of patent infringement, Sun has alleged certain defenses, including that the Sucampo Patents are invalid External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
AstraZeneca
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.